MRNA

#489
Moderna, Inc. Common Stock
53.57
+4.77%
Sector:
Base:
Profit Currency:
Daily Range
53.57
53.59
Year Range
22.29
55.19
Daily Change
+4.77%
Monthly Change
+17.79%
6 month change
+113.94%
Year Change
+73.99%
Previous Close
51.13
Open
53.59
Bid
Ask
Low
53.57
High
53.59
Volume
356
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Moderna Inc

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern". The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.

News